Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: OmertaSoldier who wrote (20718)	4/16/1999 8:51:00 PM
From: saszu	Read Replies (2) \| Respond to of 23519

People look at the book value after the earnings release: if vvus earned .12 cents per share and there is 32,000,000 shares then the book value on the company has increased by roughly $4,000,000.... now this is assuming that there are no write offs we've seen enough of those to last at least a year. so if i recall : we were in the area of 24-25 million last Q that makes us now 28-29 million in cash so my questions ???? 1) if muse sales never get much better but the base of sales get bigger its safe to say the sales will replace the milestones (were selling in a very limited amount of countries) 2)there are other product in the pipeline (mainly the one LEE talked about on FOX tonight) 3)the company is surviving in profits against the biggest drug launch in history . ************************************** ***************************** ********************* ************** ******** ** Why the fuck would anyone be short down here ha ha ha ha ha sAs